Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2026 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

united health products inc - UEEC

UEEC

Close Chg Chg %
0.06 0.00 1.09%

Closed Market

0.06

0.00 (1.09%)

Volume: 220.88K

Last Updated:

Jun 16, 2026, 2:56 PM EDT

Trade Now

Company Overview: united health products inc - UEEC

UEEC Key Data

Open

$0.06

 Day Range

0.05 - 0.06

52 Week Range

0.04 - 0.14

 Market Cap

$15.62M

Shares Outstanding

260.39M

 Public Float

237.92M

Beta

-0.28

 Rev. Per Employee

N/A

P/E Ratio

N/A

 EPS

-$0.01

Yield

0.00%

 Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

183.62K

  

UEEC Performance

1 Week
 
 -0.89%
 
1 Month
 
 -14.72%
 
3 Months
 
 -1.77%
 
1 Year
 
 -56.38%
 
5 Years
 
 -95.25%
 

UEEC Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings
Full Ratings ➔

About united health products inc - UEEC

United Health Products, Inc. engages in the development, manufacture, and marketing of wound care products based on its proprietary hemostatic gauze technology. It also offers HemoStyp to control bleeding. The company was founded on February 28, 1997 and is headquartered in Mount Laurel, NJ.

UEEC At a Glance

United Health Products, Inc.
520 Fellowship Road
Mount Laurel, New Jersey 08054
Phone 1-475-755-1005 Revenue 0.00
Industry Medical Specialties Net Income -2,669,348.00
Sector Health Technology Employees 10
Fiscal Year-end 12 / 2026
View SEC Filings

UEEC Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio N/A
Price to Book Ratio N/A
Price to Cash Flow Ratio N/A
Enterprise Value to EBITDA -7.109
Enterprise Value to Sales N/A
Total Debt to Enterprise Value 0.128

UEEC Efficiency

Revenue/Employee N/A
Income Per Employee -266,934.80
Receivables Turnover N/A
Total Asset Turnover N/A

UEEC Liquidity

Current Ratio 0.027
Quick Ratio 0.027
Cash Ratio 0.017

UEEC Profitability

Gross Margin N/A
Operating Margin N/A
Pretax Margin N/A
Net Margin N/A
Return on Assets -909.989
Return on Equity N/A
Return on Total Capital 145.695
Return on Invested Capital N/A

UEEC Capital Structure

Total Debt to Total Equity N/A
Total Debt to Total Capital -111.58
Total Debt to Total Assets 645.506
Long-Term Debt to Equity N/A
Long-Term Debt to Total Capital -13.645
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for United Health Products Inc - UEEC

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
- - - 37.50K
-
Sales Growth
- - +63,459.32% -100.00%
-
Cost of Goods Sold (COGS) incl D&A
18.64K 4.86K 4.64K 3.24K
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
4.05K 4.86K 4.64K 3.24K
Depreciation
- 807 586 (810)
Amortization of Intangibles
4.05K 4.05K 4.05K 4.05K
COGS Growth
+74,476.00% -73.95% -4.55% -30.11%
Gross Income
18.86K (4.86K) (4.64K) (3.24K)
Gross Income Growth
+55,358.82% -125.76% +4.55% +30.11%
Gross Profit Margin
- - - +50.28%
-
2022 2023 2024 2025 5-year trend
SG&A Expense
2.82M 2.42M 2.00M 2.25M
Research & Development
624.56K 598.81K 355.94K 269.87K
Other SG&A
2.20M 1.82M 1.65M 1.98M
SGA Growth
-90.53% -14.15% -17.29% +12.45%
Other Operating Expense
- - - -
-
Unusual Expense
(1.19M) 80.53K (115.08K) 242.00K
EBIT after Unusual Expense
(1.61M) (2.51M) (1.89M) (2.50M)
Non Operating Income/Expense
- - - 28.33K
-
Non-Operating Interest Income
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
78.84K 116.20K 109.25K 200.21K
Interest Expense Growth
-87.25% +47.37% -5.98% +83.26%
Gross Interest Expense
78.84K 116.20K 109.25K 200.21K
Interest Capitalized
- - - -
-
Pretax Income
(1.69M) (2.62M) (2.00M) (2.67M)
Pretax Income Growth
+94.48% -55.45% +23.69% -33.35%
Pretax Margin
- - - -4,500.00%
-
Income Tax
- - - -
-
Income Tax - Current - Domestic
- - - -
-
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
- - - -
-
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
(1.69M) (2.62M) (2.00M) (2.67M)
Minority Interest Expense
- - - -
-
Net Income
(1.69M) (2.62M) (2.00M) (2.67M)
Net Income Growth
+94.48% -55.45% +23.69% -33.35%
Net Margin Growth
- - - -4,500.00%
-
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
(1.69M) (2.62M) (2.00M) (2.67M)
Preferred Dividends
- - - -
-
Net Income Available to Common
(1.69M) (2.62M) (2.00M) (2.67M)
EPS (Basic)
-0.0074 -0.011 -0.0081 -0.0104
EPS (Basic) Growth
+94.53% -48.65% +26.36% -28.40%
Basic Shares Outstanding
229.72M 239.08M 248.17M 256.98M
EPS (Diluted)
-0.0074 -0.011 -0.0081 -0.0104
EPS (Diluted) Growth
+94.53% -48.65% +26.36% -28.40%
Diluted Shares Outstanding
229.72M 239.08M 248.17M 256.98M
EBITDA
(2.80M) (2.42M) (2.00M) (2.25M)
EBITDA Growth
+90.61% +13.45% +17.29% -12.45%
EBITDA Margin
- - - -7,461.31%
-

United Health Products Inc in the News